Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $2.28 billion. The enterprise value is $2.14 billion.

Market Cap	2.28B
Enterprise Value	2.14B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, before market open.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Belite Bio has 32.83 million shares outstanding. The number of shares has increased by 1.56% in one year.

Current Share Class	n/a
Shares Outstanding	32.83M
Shares Change (YoY)	+1.56%
Shares Change (QoQ)	-5.49%
Owned by Insiders (%)	1.39%
Owned by Institutions (%)	0.45%
Float	15.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	15.11
P/TBV Ratio	15.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.15

Current Ratio	23.15
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,284.10

Financial Efficiency

Return on equity (ROE) is -17.33% and return on invested capital (ROIC) is -12.14%.

Return on Equity (ROE)	-17.33%
Return on Assets (ROA)	-11.68%
Return on Invested Capital (ROIC)	-12.14%
Return on Capital Employed (ROCE)	-17.13%
Revenue Per Employee	n/a
Profits Per Employee	-$916,480
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Belite Bio has paid $12,000 in taxes.

Income Tax	12,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.71% in the last 52 weeks. The beta is -1.50, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.50
52-Week Price Change	+41.71%
50-Day Moving Average	64.76
200-Day Moving Average	62.23
Relative Strength Index (RSI)	59.70
Average Volume (20 Days)	33,580

Short Selling Information

Short Interest	180,333
Short Previous Month	189,112
Short % of Shares Out	1.18%
Short % of Float	n/a
Short Ratio (days to cover)	3.89

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.68M
Pretax Income	-31.62M
Net Income	-22.91M
EBITDA	-25.50M
EBIT	-25.68M
Earnings Per Share (EPS)	-$0.78

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	149.89M
Book Value Per Share	4.60
Working Capital	144.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.56%
Shareholder Yield	n/a
Earnings Yield	-1.00%
FCF Yield	n/a

Analyst Forecast

The average price target for Belite Bio is $96.00, which is 40.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$96.00
Price Target Difference	40.10%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a